Jump Financial, LLC Black Diamond Therapeutics, Inc. Transaction History

Jump Financial, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.67 - $5.74 $1,121 - $2,410	-420 Reduced 1.08%	38,468 $195,000
Q4 2023 Oct 21, 2024	BUY	$1.77 - $3.03 $48,880 - $83,676	27,616 Added 245.0%	38,888 $109,000
Q4 2023 Feb 07, 2024	BUY	$1.77 - $3.03 $48,880 - $83,676	27,616 Added 245.0%	38,888 $109,000
Q3 2023 Oct 21, 2024	BUY	$2.87 - $4.99 $32,350 - $56,247	11,272 New	11,272 $32,000
Q3 2023 Nov 07, 2023	BUY	$2.87 - $4.99 $32,350 - $56,247	11,272 New	11,272 $32,000
Q2 2022 Aug 09, 2022	SELL	$1.5 - $3.63 $17,848 - $43,193	-11,899 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.66 - $5.61 $72,886 - $153,719	-27,401 Reduced 69.72%	11,899 $33,000
Q4 2021 Feb 10, 2022	BUY	$5.18 - $8.48 $203,574 - $333,264	39,300 New	39,300 $209,000
Q3 2021 Nov 12, 2021	SELL	$8.46 - $12.42 $177,863 - $261,118	-21,024 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$12.19 - $28.17 $256,282 - $592,246	21,024 New	21,024 $256,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.